Top Markets
Coin of the day
Hepion Pharmaceuticals, Inc. Hepion Pharmaceuticals, Inc.

Hepion Pharmaceuticals, Inc.

HEPA
Rang în acțiuni #39071
Hepion Pharmaceuticals, Inc., a U.S.-based biopharmaceutical entity, is... Hepion Pharmaceuticals, Inc., a U.S.-based biopharmaceutical entity, is dedicated to developing therapeutic interventions for chronic hepatic ailments. Central to their efforts is Rencofilstat, a cyclophilin inhibitor that has successfully concluded Phase 2a clinical trials. This compound operates by disrupting multiple pathological pathways implicated in the worsening of liver disease. It is currently progressing through clinical development for non-alcoholic steatohepatitis (NASH) and is additionally being explored in nonclinical research for its potential to reduce liver fibrosis and lessen hepatocellular carcinoma tumor loads in experimental models of NASH. Moreover, Rencofilstat has exhibited antiviral properties against hepatitis B, C, and D viruses through diverse mechanisms. The company, established in 2013 and situated in Edison, New Jersey, rebranded as Hepion Pharmaceuticals, Inc. in July 2019, having previously operated as ContraVir Pharmaceuticals, Inc.
Preț acțiune
$0.0568
Ultima sincronizare: 2026-08-13
Capitalizare de piață
$661.36K
Schimbare (1 zi)
11.37%
Schimbare (1 an)
-5.33%
Țară
US
Tranzacționează Hepion Pharmaceuticals, Inc. (HEPA)

Categorie

Prețul HEPA cu capitalizarea de piață a B
Hepion Pharmaceuticals, Inc. Hepion Pharmaceuticals, Inc.
HEPA
$0.0568
Capitalizarea de piață a Hepion Pharmaceuticals, Inc.(HEPA)
Capitalizare de piață: $661.36K
În anul August 2026, Hepion Pharmaceuticals, Inc. are o capitalizare de piață de $661.36K. Acest lucru face ca Hepion Pharmaceuticals, Inc. să fie a 39071st-a cea mai valoroasă companie din lume, conform datelor noastre. Capitalizarea bursieră reprezintă valoarea totală de piață a acțiunilor în circulație ale unei companii listate și este utilizată frecvent pentru a măsura valoarea unei companii.
Istoricul capitalizării de piață a Hepion Pharmaceuticals, Inc. din 2014 până în 2026
HEPA în comparație cu top 5 cele mai populare stocks
Prețul pentru HEPA Activul B Capitalizarea de piață a B Rezultate
Hepion Pharmaceuticals, Inc. Hepion Pharmaceuticals, Inc.
$469,742 $661.36K
$5.470T +827,009,900.33%
Hepion Pharmaceuticals, Inc. Hepion Pharmaceuticals, Inc.
$383,647 $661.36K
$4.467T +675,434,042.20%
Hepion Pharmaceuticals, Inc. Hepion Pharmaceuticals, Inc.
$358,510 $661.36K
$4.174T +631,179,244.65%
Hepion Pharmaceuticals, Inc. Hepion Pharmaceuticals, Inc.
$317,775 $661.36K
$3.700T +559,462,337.44%
Hepion Pharmaceuticals, Inc. Hepion Pharmaceuticals, Inc.
$245,140 $661.36K
$2.854T +431,584,807.66%